Health Care • Hospital/Nursing Management
$34.25 ▲ +0.65
(+1.94%)
MKT CAP: $1.65B • VOL: 392.7K
52W L $25 52W H $44
ROARABLE / RQD
E • 31/100
PIOTROSKI
3 / 9
CONSENSUS RATING DISTRIBUTION (40 DESKS)
BUY: 30 HOLD: 8
SELL: 2
12M STREET TARGET RANGE
IMPLIED: +14.0%
LOW
$29
MEDIAN
$38
MEAN
$39
HIGH
$47
STREET BS CREDIBILITY SCORE 1Y BACKTESTED
68/100
EMPIRICAL HIT RATE VS SPOT
GRADES WHETHER SELL-SIDE TARGET REVISIONS LEAD OR CHASE SNDA TAPE
SNDA // FIRM-BY-FIRM ANALYST BACKTEST & BS DETECTOR (ANR <GO>)
CURRENT 90D STREET CONSENSUS
| INSTITUTION / ANALYST | ACTION | RATING | TARGET | PRIOR PT | CALL DATE | PX AT CALL | RET SINCE CALL | 1Y ACCURACY | BS GRADE |
|---|---|---|---|---|---|---|---|---|---|
| Morgan Stanley Institutional Equity Desk | REITERATE | OUTPERFORM | $41.44 | $39.39 | 2025-02-14 | $31.17 | +9.9% | 78% | A |
| Goldman Sachs Global Research Sector Coverage | TARGET REV | STRONG BUY | $43.16 | $40.41 | 2025-02-06 | $32.20 | +6.4% | 74% | A |
| J.P. Morgan Securities US Large Cap | REITERATE | BUY | $39.04 | $37.68 | 2025-01-29 | $32.88 | +4.2% | 67% | B |
| Bernstein Autonomous Forensic Coverage | INITIATE | HOLD | $34.94 | — | 2025-01-17 | $33.56 | +2.0% | 61% | B |
| Barclays Capital Americas Research | DOWNGRADE | UNDERPERFORM | $30.14 | $32.54 | 2025-01-09 | $30.48 | -11.2% | 42% | D |
| UBS Investment Bank Institutional Desk | UPGRADE | BUY | $40.76 | $35.62 | 2024-12-18 | $29.80 | +14.9% | 72% | A |
| Citigroup Global Markets Sector Lead | TARGET REV | HOLD | $33.22 | $34.59 | 2024-12-04 | $31.85 | -4.3% | 48% | C |